Point of Care Lipid Test Market to Reach $426.58 Million, Globally, by 2031 at 4.1% CAGR: Allied Market Research

PORTLAND, Ore., Jan. 25, 2023 /PRNewswire/ -- Surge in obesity in populace, increase in government initiatives to promote healthy lifestyle and increase in prevalence of cardiovascular disease and diabetes drive the growth of the global point of care lipid test market.

A new business intelligence report released by Allied Market Research with title, "Point of Care Lipid Test Market by Product Type (Devices and Consumables), Application (Endogenous Hyperlipidemia, Combined Hyperlipidemia, Familial Hypercholesterolemia, and Others), and End User (Hospitals and Clinics, Diagnostic Laboratories, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global point of care lipid test industry generated $284.86 million in 2021, and is estimated to reach $426.58 million by 2031, witnessing a CAGR of 4.1% from 2022 to 2031. The report offers a detailed analysis of changing market trends, top segments, key investment pockets, value chains, regional landscapes, and competitive scenarios.

Download Free Sample Report: https://www.alliedmarketresearch.com/request-sample/14415

Drivers, Restraints, and Opportunities-

Surge in obesity in populace, increase in government initiatives to promote healthy lifestyle and increase in prevalence of cardiovascular disease and diabetes drive the growth of the global point of care lipid test market. On the other hand, high cost of product development restrains the growth to some extent. However, growth potential in emerging economies is expected to create lucrative opportunities in the industry.

Covid-19 scenario-

• Majority of the point of care lipid test centers experienced a broad spectrum of difficulties, and most were affected more in the second wave of the pandemic This factor impacted the market negatively.
• However, the global market for point of care lipid test has recovered slowly and steadily.

The consumables segment to maintain its dominance during the forecast period-

By product type, the consumables segment held the largest share in 2021, garnering nearly three-fourth of the global point of care lipid test market revenue, and is projected to maintain its dominance by 2031. The same segment would also showcase the fastest CAGR of 4.5% during the forecast period. This is driven by the increase in use of consumables in many instruments either in laboratories or point-of-care which help buyers to operate these instruments efficiently.

The endogenous hyperlipidemia segment to rule the roost-

By application, the endogenous hyperlipidemia segment contributed to more than three-fourth of the global point of care lipid test market share in 2021, and is projected to rule the roost by 2031. This is attributed to increase in prevalence of lipid disorders due to a high-fat diet and sedentary lifestyle. The familial hypercholesterolemia segment on the other hand would display the fastest CAGR of 5.2% throughout the forecast period. increase in diagnosis and treatment adoption rate fuel the segment growth.

Purchase Inquiry: https://www.alliedmarketresearch.com/purchase-enquiry/14415

The diagnostic laboratories segment to rule the roost-

By end user, the diagnostics laboratories segment contributed to more than two-thirds of the global point of care lipid test market share in 2021, and is projected to rule the roost by 2031. This is attributed to diagnostic laboratories performs various tests to determine the cause of the condition. The others segment on the other hand would display the fastest CAGR of 5.0% throughout the forecast period. It can help someone who is aging and is managing chronic health issues; is recovering from a medical setback; or has special needs or a disability fuel the segment growth.

North America garnered the major share in 2021-

By region, North America held the major share in 2021, garnering more than three-fifths of the global point of care lipid test market revenue, and is expected to dominate by 2031. This is due to the substantial presence of major pharmaceutical and biopharmaceutical companies in the North American region Asia-Pacific, on the other hand, would showcase the fastest CAGR of 5.4% from 2022 to 2031.

Leading Market Players-

• Abbott Laboratories
• Callegari
• F. Hoffmann-La Roche Ltd.
• Menarini Group
• Mico Bio Med
• Nova Biomedical Corporation
• SD biosensor, inc.
• Sinocare Inc.
• VivaChek Biotech (Hangzhou) Co.,Ltd,
• Zoetis Inc.

The report analyzes these key players in the global point of care lipid test market. These players have adopted various strategies such as product development, market expansion and agreement to increase their market penetration and strengthen their position in the industry. The report is helpful in determining the business performance, operating segments, developments, and product portfolios of every market player.

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Laser BPH Devices Market by Type (Holmium laser, Thulium laser, Green light laser, Others), by Procedure (Photoselective Vaporisation of the Prostate, Holmium laser ablation of the prostate), by End User (Hospitals, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Healthcare Staffing Market by Type (Allied Healthcare Staffing, Per Diem Nurse Staffing, Travel Nursing, Locum Tenens Staffing), by End-user (Hospitals, Clinics, Clients, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Tissue Expanders Market by Lesion Site (Lower Extremity, Upper Extremity, Others), by Product Shape (Rectangular, Crescent, Round, Others), by End User (Hospitals, Cosmetic Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Immune Checkpoint Inhibitor Market by Type (PD-1 Inhibitor, PD-L1 Inhibitor, and CTLA-4 Inhibitor) and Application (Lung Cancer, Bladder Cancer, Melanoma, Hodgkin Lymphoma, Colorectal Cancer and Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Sleep Apnea Implants Market by Product Type (Hypoglossal Neurostimulation Devices, Phrenic Nerve Stimulator, Others), by Indication (Obstructive Sleep Apnea, Central Sleep Apnea), by End User (Hospitals, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com

Logo - https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/point-of-care-lipid-test-market-to-reach-426-58-million-globally-by-2031-at-4-1-cagr-allied-market-research-301730451.html